In Conversation: David Vanik, Ph.D., Partner at McBee Moore & Vanik IP

Headshot of David Vanik of MMVIP
Published on :

Since the days of working on his Ph.D. in protein science, David Vanik has had an interest in intellectual property and patent law. As Vanik closed in on completing his doctoral research, he began to look at IP within the area of biotechnology.

McBee, Moore & Vanik IP: Intellectual Property Law Firm Celebrates Six Years

Published on :

McBee, Moore & Vanik IP, LLC began in 2016 when partners Susan McBee, C.G. Moore, David Vanik and 12 employees came together to form a new patent law firm with improved client service as the ultimate goal. This year, the firm is celebrating six years together. 

Veralox, McBee Moore & Vanik IP, LLC and the Importance of Patent Protection

Published on :

Intellectual property is the lifeblood of biopharmaceutical companies. Protection of that information is of paramount importance and it is one reason companies seek legal firms that specialize in intellectual property and patent protection.

5 Questions With Priscilla Fussell, Ph.D., J.D., Associate at McBee, Moore & Vanik IP, LLC

Published on :

Dr. Fussell represents a diverse array of clients in various intellectual property matters, including patent and trademark prosecution and litigation. She performs due diligence, freedom-to-operate, validity, and patentability analyses in the chemical and life sciences industries. She has a wide range of experience in the biotechnology, pharmaceutical, and chemical arts, including medical devices, biofuels, probiotics, plants, herbicides, fertilizers, seeds, nucleic acids, proteins, enzymes, carbohydrates, diagnostics, methods of treating cancer, cancer diagnostics, and agents for treating cancer. Dr. Fussell has negotiated and drafted a wide variety of agreements relating to intellectual property interests, including settlement agreements.

2021 Mid-Atlantic Science and Technology Virtual Showcase

Published on :

The ISPE Chesapeake Bay Area Chapter Mid-Atlantic Science & Technology (MAST) Virtual Showcase, hosted on May 19th, 2021, provided a platform for life science companies to discuss strategies for addressing challenges in the life science industry.

Patent for Patients: A Boon for Cancer Immunotherapy

Published on :

Over the recent decades, cancer immunotherapy research has made significant advances. In our continued quest to cure cancer, a commercial incentive is necessary to counterbalance the costs and risks associated with the research and development of cancer immunotherapies and to encourage new inventions.

Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field

Published on :

Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field McBee, Moore & Vanik Had 247 Patents Issued [….]